AKT1 and metastatic malignant neoplasm: Although typically the PI3K/AKT pathways has been considered primarily to be responsible for survival signalling and proliferation, there is accumulating evidence to suggest that Akt signalling contributes to cellular motility, including in metastatic cancer cells19.